Chief Technical Officer · Dianthus Therapeutics, Inc. (DNTH)

David Nichols

FY2021 is the first fiscal year CompBrief holds for David Nichols as a named executive officer of Dianthus Therapeutics; the record below is that year, complete. Every figure below is printed as the company filed it and cited to the filing it came from.

Total disclosed compensation, FY2021

$1,661,676

Salary $246,591Stock awards $0Bonus $40,000

3rd of 3 named executive officers at Dianthus Therapeutics by FY2021 total.

3 named officers on file for Dianthus Therapeutics, FY2021

David Nichols’s pay file — $29

  • 1 fiscal year of pay, line by line
  • 1 equity grant, each cited to its filing
  • DNTH’s disclosed peer group of 19 companies

A PDF and a CSV sent to your email. Every row is cited to its filing.

One-time report. No refunds.

See an example →

Velarion Intel · free for 3 days · no card

See how Dianthus Therapeutics’s whole pay program stands against its peers

  • Dianthus Therapeutics’s company dashboard and its AI-written, board-ready brief, every figure cited to the filing
  • Peer-group intelligence, custom peer reruns and governance screens
  • Every other company we cover, with alerts when they file
Start my free trial on DNTH→

No card. Nothing is charged, and the trial ends on its own.

Compensation figures as of the proxy filed May 2, 2022 (DEF 14A).

Free

Get David Nichols’s full pay file as a PDF — free

More than this page: up to 10 years of David’s pay history, a side-by-side peer comparison, and a one-page board summary — the whole file, yours now and by email.

David Nichols compensation by year

Dianthus Therapeutics Summary Compensation Table · the one fiscal year held
In US dollars, as Dianthus Therapeutics reports it. Most recent year shaded. Totals are the company’s disclosed totals.
ComponentFY2021
Salary$246,591
Bonus$40,000
Stock awards$0
Option awards$1,272,752
Non-equity incentive$98,000
Pension and deferred compensation$0
All other$4,333
Total$1,661,676

Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: Dianthus Therapeutics, Inc. DEF 14A filed May 2, 2022, accession 0001193125-22-136711, and prior-year filings. Open the filing on EDGAR.

How this page was built: the Dianthus Therapeutics, Inc. filed document, accession 0001193125-22-136711. Every figure is read from that document and cited to the page and table it appears in. Filed May 2, 2022.

Equity holdings

unvested awards at FY2021 year-end
TypeUnvested unitsValue at year-endExercise price
PSU20,000$88,600—
Option175,000—$10.50

Per the Outstanding Equity Awards at Fiscal Year-End table in Dianthus Therapeutics, Inc.'s FY2021 proxy; value at the fiscal year-end close, as the company printed it.

Dianthus Therapeutics’s named executive officers, FY2021

as the company reported each
Named executive officerRoleFY2021 total
D.Phil. Jason GardnerPresident and Chief Executive Officer (5)$2,228,102
Thomas BeethamChief Legal Officer (6)$1,894,380
David Nichols · this pageChief Technical Officer$1,661,676

The full Dianthus Therapeutics compensation record

free company brief

This page is one person within Dianthus Therapeutics's record. The company brief lists every named executive, each linking to their own page.

Peer companies

named in the Dianthus Therapeutics proxy · each links to its own free brief

Compensation, the day it’s disclosed

The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them.

How this record is built

Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are Dianthus Therapeutics's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.

David Nichols's compensation dossier · One-time report. No refunds.